Somma Lombardo, Italy

Cosima Minelli

This inventor holds 1 USPTO granted patent. Top assignee: Chemo Iberica, S.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cosima Minelli. Retrieved from https://idiyas.com/inventor/cosima-minelli

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Cosima Minelli

Introduction

Cosima Minelli is a notable inventor based in Somma Lombardo, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of important compounds. Her work exemplifies the intersection of innovation and practical application in the medical industry.

Latest Patents

Cosima holds a patent for a novel process for the production of sitagliptin. The IUPAC name for this compound is 7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1 2,4,5-triazolo[4,3-a]pyrazine. This innovative process enhances the efficiency of synthesizing sitagliptin, which is crucial for diabetes management.

Career Highlights

Cosima is currently employed at Chemo Iberica, S.A., where she continues to push the boundaries of pharmaceutical research. Her dedication to her work has led to advancements that benefit both the industry and patients alike.

Collaborations

Throughout her career, Cosima has collaborated with esteemed colleagues such as Marcello Rasparini and Roberto Rocco Tufaro. These partnerships have fostered a creative environment that encourages the sharing of ideas and expertise.

Conclusion

Cosima Minelli's contributions to the field of pharmaceuticals through her innovative processes highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has a meaningful impact on healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…